Abstract
ABSTRACT Introduction Gastroesophagealreflux disease (GERD) is a chronic disease of the esophagus characterized bythe regurgitation of stomach contents into the esophagus causing troublesomesymptoms and/or complications. Among patients with GERD, around 30% of patientshave visible mucosal damage, while 70% have a normal esophageal mucosa. Accordingly,the optimal pharmacological treatment of GERD should address different diseasemanifestations, including symptoms, the mucosal damage when present, and possiblechronic complications, including strictures, Barrett’s esophagus, andesophageal adenocarcinoma. Areascovered Available medicaltreatments for GERD include proton pump inhibitors (PPIs),potassium-competitive acid blockers (PCABs), histamine receptor antagonists (H2-RAs),prokinetics, and mucosal protectants such as alginates, hyaluronicacid/chondroitin-sulfate, and poliprotect. Each compound has its ownadvantages and disadvantages, and knowledge of expected benefits and tips fortheir use are paramount for the success of treatment. In addition, theappropriateness of indications for initiating treatment is also crucial toachieve positive results when managing GERD patients. Expertopinion PPIs,PCABs, H2-RAs, prokinetics, and mucosal protectants can all be used in patientswith GERD, but careful assessment of patients’ characteristics as well asadvantages and disadvantages of each therapeutic compound is essential toensure successful treatment of GERD.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
